SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-22-028397
Filing Date
2022-10-14
Accepted
2022-10-13 20:59:19
Documents
9
Period of Report
2022-10-13

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 23576
2 ex1.htm EX-1 773514
3 ex2.htm EX-2 13886
4 ex3.htm EX-3 13732
5 ex4.htm EX-4 247616
6 ex5.htm EX-5 94101
7 ex1_001.jpg GRAPHIC 19193
8 ex1_002.jpg GRAPHIC 21119
9 ex4_001.jpg GRAPHIC 19193
  Complete submission text file 0001493152-22-028397.txt   1250048
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 221310115
SIC: 2834 Pharmaceutical Preparations